Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

B Hajarizadeh, EB Cunningham, H Valerio… - Journal of …, 2020 - Elsevier
Background & Aims HCV reinfection following successful treatment can compromise
treatment outcomes. This systematic review assessed the rate of HCV reinfection following …

Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression

S Hosseini-Hooshyar, B Hajarizadeh, S Bajis… - The lancet HIV, 2022 - thelancet.com
Background The benefits of direct-acting antivirals towards the elimination of hepatitis C
virus (HCV) in people living with HIV are decreased when individuals are reinfected with …

[图书][B] Best practices in child and adolescent tuberculosis care

World Health Organization - 2018 - apps.who.int
The global tuberculosis (TB) and child health community has increasingly prioritized the
childhood TB epidemic. In 2013, the childhood TB subgroup developed and published the …

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

J Grebely, O Dalgard, B Conway… - The lancet …, 2018 - thelancet.com
Background Despite revised guidelines that no longer exclude people who inject drugs
(PWID) from treatment for hepatitis C virus (HCV) infection, many clinicians are reluctant to …

[HTML][HTML] The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver

H Shah, M Bilodeau, KW Burak, C Cooper, M Klein… - Cmaj, 2018 - Can Med Assoc
The treatment of hepatitis C has become safer, better tolerated and more effective owing to
the availability of direct-acting antivirals for nearly all patients; this guideline advocates …

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort

C Rossi, ZA Butt, S Wong, JA Buxton, N Islam, A Yu… - Journal of …, 2018 - Elsevier
Background & Aims Direct-acting antiviral therapies (DAA) are an important tool for hepatitis
C virus (HCV) elimination. However, reinfection among people who inject drugs (PWID) may …

The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals

SR Bartlett, A Yu, N Chapinal, C Rossi, Z Butt… - Liver …, 2019 - Wiley Online Library
Background Population‐level monitoring of hepatitis C virus (HCV) infected people across
cascades of care identifies gaps in access and engagement in care and treatment. We …

[HTML][HTML] Interventions to prevent HIV and Hepatitis C among people who inject drugs: latest evidence of effectiveness from a systematic review (2011 to 2020)

N Palmateer, V Hamill, A Bergenstrom… - International Journal of …, 2022 - Elsevier
Abstract Background Hepatitis C virus (HCV) and HIV remain prevalent among people who
inject drugs (PWID) and transmission is usually associated with injecting risk behaviour …

Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era

O Falade‐Nwulia, MS Sulkowski… - Journal of viral …, 2018 - Wiley Online Library
The availability of effective, simple, well‐tolerated oral direct‐acting antiviral (DAA) hepatitis
C regimens has raised optimism for hepatitis C virus (HCV) elimination at the population …

Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets

NZ Janjua, N Islam, M Kuo, A Yu, S Wong… - International Journal of …, 2018 - Elsevier
Background Large linked healthcare administrative datasets could be used to monitor
programs providing prevention and treatment services to people who inject drugs (PWID) …